ClearPoint Neuro (CLPT) Other financing activities (2011 - 2026)
ClearPoint Neuro (CLPT) reported Other financing activities of $148000.0 for Q1 2026, up 604.76% on a YoY basis from $21000.0 in Q1 2025, and up 180.43% sequentially from -$184000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Other financing activities (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Other financing activities data on file, last reported at $148000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 604.76% year-over-year to $148000.0; the trailing twelve-month figure through Mar 2026 stood at $254000.0 (up 1109.52% YoY), and the FY2025 full-year result was $127000.0, up 504.76% from the prior year.
- Other financing activities climbed to $148000.0 in Q1 2026, from -$184000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $314000.0 in Q2 2023 to a low of -$314000.0 in Q3 2023.
- A 5-year average of $51300.0 and a median of $84500.0 in 2024 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities slipped 3.12% in 2022 and jumped 604.76% in 2026, its largest moves.
- Tracing CLPT's Other financing activities over 5 years: stood at $217000.0 in 2022, then plunged by 244.7% to -$314000.0 in 2023, then grew by 14.97% to -$267000.0 in 2024, then jumped by 31.09% to -$184000.0 in 2025, then jumped by 180.43% to $148000.0 in 2026.
- Business Quant data shows CLPT's Other financing activities at $148000.0 in Q1 2026, -$184000.0 in Q4 2025, and $290000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,000.00 |
| Mar 31, 2026 | 148,000.00 |
| Dec 31, 2025 | -184,000.00 |
| Dec 31, 2025 | -184,000.00 |
| Jun 30, 2025 | 290,000.00 |
| Jun 30, 2025 | 290,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | -267,000.00 |
| Dec 31, 2024 | -267,000.00 |
| Sep 30, 2024 | 267,000.00 |
| Sep 30, 2024 | 267,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Sep 30, 2023 | -314,000.00 |
| Sep 30, 2023 | -314,000.00 |
| Jun 30, 2023 | 314,000.00 |
| Jun 30, 2023 | 314,000.00 |
| Dec 31, 2022 | 217,000.00 |
| Dec 31, 2022 | 217,000.00 |